SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-23-012871
Filing Date
2023-09-29
Accepted
2023-09-29 16:45:24
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 d9282306k.htm   iXBRL 6-K 569639
  Complete submission text file 0001214659-23-012871.txt   2907466

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bdrx-20230630.xsd EX-101.SCH 37634
3 XBRL CALCULATION FILE bdrx-20230630_cal.xml EX-101.CAL 43294
4 XBRL DEFINITION FILE bdrx-20230630_def.xml EX-101.DEF 64379
5 XBRL LABEL FILE bdrx-20230630_lab.xml EX-101.LAB 193634
6 XBRL PRESENTATION FILE bdrx-20230630_pre.xml EX-101.PRE 159800
45 EXTRACTED XBRL INSTANCE DOCUMENT d9282306k_htm.xml XML 513880
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 231296333
SIC: 2834 Pharmaceutical Preparations